Clinical Trial Update: Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating three months of weekly rifapentine and isoniazid for preventing tuberculosis after M. tuberculosis infection has completed. Results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection
• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)
• rifapentine (rifapentine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Tuberculosis | Phase 3 | Status: COMPLETED | Results posted: 2012-09-27